How Patent Expirations Will Reshape The Dry Powder Inhaler (PDI) Market

By Tom Bailey

Upcoming patent expirations on dry powder inhaler (DPI) platforms are shifting a market once ruled by a few originators into a crowded race for generics. Winning this market depends less on novel device design and more on mastering technical production. Achieving speed to market is vital, as early generic entrants secure most profits before rapid price erosion sets in.

Fine, cohesive powders frequently segregate during pneumatic or vacuum-based filling, disrupting blend homogeneity and dose accuracy. Mechanical dosing methods preserve formulation integrity, enabling seamless scale-up and high manufacturing yields without process-induced delays. Rather than depending on end-of-line inspection equipment to spot defects, manufacturers can establish stable, controlled operations from the start. Explore the full article to discover how robust powder-filling strategies accelerate commercial production and protect profit margins.